IRIS ACQUISITION CORP Warrant 02/28/2028

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IRAAW and buy or sell other stocks, ETFs, and their options commission-free!

About IRAAW

Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA. 

CEO
Chris Kim
CEOChris Kim
Employees
—
Employees—
Headquarters
Cerritos, California
HeadquartersCerritos, California
Founded
Founded
Employees
—
Employees—

IRAAW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
13.79K
Average volume13.79K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.15
52 Week high$0.15
52 Week low
$0.005
52 Week low$0.005

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.